SCIENCE Q&A: Tom Sellig on Why Complex Formulations Are Driving CDMO Growth Friday, June 12, 2026 Advertisement Read Original Article → Related Dispatches [US] · Jun 12 Thryv Therapeutics synthesizes SGK1 inhibitors [US] · Jun 12 Politico’s Climate News Site Shutters A Year After Gov’t Turned Off Taxpayer Spigot [US] · Jun 12 Crow Wing County approves vendor for outdoor warning siren maintenance